{'fraction_non_alphanumeric': 0.01876675603217158, 'fraction_numerical': 0.0, 'mean_word_length': 4.746153846153846, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
AZT trials pose difficult breast-feeding dilemma.


 International AIDS experts and HIV infected women in Africa may soon face an impossible dilemma if short-term AZT treatment prevents perinatal transmission. HIV-infected mothers may not be able to afford infant formula or may not have access to safe water to mix with the formula, and may expose the child to HIV again through breast feeding. Few studies have addressed the breast feeding issue, although a controversial placebo-controlled study is underway in Nairobi. Pediatricians have promoted breast feeding as the preferred means to feed infants, and in many cases, mothers do not have other viable choices. Women who cannot afford formula may be forced to expose their children to HIV.
